"nctid","reason_for_termination","anticipated_enrollment","actual_enrollment","has_summary_result","start_date","stop_date","trial_days","source"
"NCT00150878","Insurance coverage reached",172,198,FALSE,"2003-12-01","2009-12-01",2192,"Intovalue"
"NCT00480077","Low enrollment rates",2300,335,TRUE,"2007-03-01","2012-01-01",1767,"Intovalue"
"NCT00618384","[No reason posted]",72,43,FALSE,"2008-01-01","2011-05-01",1216,"Intovalue"
"NCT00640679","Due to slow enrollment the study was stopped prematurely.",3000,782,FALSE,"2008-04-01","2012-08-01",1583,"Intovalue"
"NCT00672334","[No reason posted]",402,350,FALSE,"2008-05-01","2011-06-01",1126,"Intovalue"
"NCT00690118","The interim analysis showed no tendency in favour of the verum group. Therefore it was decided to stop the study prematurely.",220,219,FALSE,"2008-05-01","2011-01-01",975,"Intovalue"
"NCT00716833","poor recruitment",120,87,FALSE,"2006-02-01","2010-12-01",1764,"Intovalue"
"NCT00798525","Supply of Lepirudin ended on 01. April 2012, thus trial terminated on 31. March 2012",240,70,FALSE,"2009-01-01","2012-03-01",1155,"Intovalue"
"NCT00803309","At the end of the planned recruitment period the expected number of subjects could not be included in the trial.",150,99,FALSE,"2008-11-01","2013-08-01",1734,"Intovalue"
"NCT00986258","This clinical trial was terminated early, due to slow recruitment and study drug shortages.",180,136,TRUE,"2009-10-01","2010-12-01",426,"Intovalue"
"NCT00996554","Feasibility reasons; recruitment was too slow.",942,252,FALSE,"2004-01-01","2012-01-01",2922,"Intovalue"
"NCT00999856","Two cohorts successfully completed; further cohorts not needed; no safety issue!",65,28,FALSE,"2008-08-01","2012-03-01",1308,"Intovalue"
"NCT01021423","Terminated by sponsor due to new unpublished data that rendered the current design of the study no longer clinically relevant. There were no safety concerns.",382,9,TRUE,"2010-04-01","2011-03-01",334,"Intovalue"
"NCT01030666","shelf life of investigational drug ran out before 90 patients could be included",NA,61,TRUE,"2007-04-01","2011-01-01",1371,"Intovalue"
"NCT01143272","Masked independent interim analysis: completion of the trial was unlikely.",1520,477,TRUE,"2010-06-01","2012-11-01",884,"Intovalue"
"NCT01178255","recruitment difficulties",228,44,FALSE,"2010-08-01","2011-11-01",457,"Intovalue"
"NCT01239992","negative endpoint study resulting in withdrawal of study drug",20,12,TRUE,"2011-06-01","2013-01-01",580,"Intovalue"
"NCT01297712","enrollment terminated, analysis ongoing",NA,1069,FALSE,"2009-09-01","2010-11-01",426,"Intovalue"
"NCT01339026","Change in guidelines favouring newer antiplatelet drugs in ACS",140,44,FALSE,"2012-02-01","2013-09-01",578,"Intovalue"
"NCT01564095","Missing evidence of the effectiveness of the study medication",86,25,FALSE,"2011-10-01","2013-07-01",639,"Intovalue"
"NCT01601496","Slow Enrollment",150,117,TRUE,"2009-10-26","2013-07-24",1367,"Intovalue"
"NCT00626548","early efficacy review by the Independent Data Monitoring Committee indicated it was unlikely to meet its primary efficacy endpoints",1500,2577,TRUE,"2008-01-01","2011-03-01",1155,"Intovalue"
"NCT00746720","Patient recruitment difficulties",52,23,FALSE,"2006-05-01","2009-07-01",1157,"Intovalue"
"NCT00368121","Lack of recruitable patients",33,13,FALSE,"2006-08-01","2012-06-01",2131,"Intovalue"
"NCT00502554","insufficient patient recruitment and ECP capacity",20,12,FALSE,"2007-08-01","2010-04-01",974,"Intovalue"
"NCT00663104","[No reason posted]",126,126,FALSE,"2008-04-01","2009-06-01",426,"Intovalue"
"NCT00667667","[No reason posted]",108,108,FALSE,"2008-04-01","2009-06-01",426,"Intovalue"
"NCT00708942","Slow recruitment, study stopped with only 13 of 70 patients included in second part of the study",150,83,TRUE,"2009-01-01","2012-01-01",1095,"Intovalue"
"NCT00720850","Low recruitment, scientific rationale not applicable anymore to all patients and possible induction of GvHD by the study drug",50,10,FALSE,"2008-04-01","2011-01-01",1005,"Intovalue"
"NCT00823290","Investigator left site",18,2,FALSE,"2009-01-01","2010-12-01",699,"Intovalue"
"NCT00933374","delayed recruitment",30,28,FALSE,"2009-07-01","2012-11-01",1219,"Intovalue"
"NCT01079091","The foundations of our pilotstudy planning has changed.",160,14,FALSE,"2010-09-01","2013-07-01",1034,"Intovalue"
"NCT01079104","The foundations of our pilotstudy planning has changed.",184,7,FALSE,"2010-09-01","2013-08-01",1065,"Intovalue"
"NCT01187888","IMP used off label by phys. in pat. with PSP. Thus no more eligible patients were available for the study(pre-treatm.with Rasagiline=exclusion criterion",112,44,FALSE,"2010-01-01","2012-06-01",882,"Intovalue"
"NCT01215266","Slow recruitment",NA,98,FALSE,"2006-10-01","2011-06-01",1704,"Intovalue"
"NCT01245985","slow recruitment (only 8 patients recruited and treated until 12&#x2F;2012)",50,8,FALSE,"2010-11-01","2012-11-01",731,"Intovalue"
"NCT00125606","insufficient patient recruitement",172,30,FALSE,"2004-10-01","2011-07-01",2464,"Intovalue"
"NCT00331721","Scientific data called into question the viability of the substance class",72,24,FALSE,"2006-05-01","2009-05-01",1096,"Intovalue"
"NCT00368264","Failure to recruit patients with membranous lupus nephritis not previously treated with azathioprine .",44,1,FALSE,"2006-09-01","2009-06-01",1004,"Intovalue"
"NCT00405873","Lack of efficacy",NA,73,FALSE,"2007-03-01","2010-03-01",1096,"Intovalue"
"NCT00457951","Interim analysis: safety without efficacy ODSH in patients with acute COPD.",66,158,TRUE,"2007-04-01","2009-08-01",853,"Intovalue"
"NCT00511160","Study suspended due to logistical&#x2F;personnel difficulties",120,120,FALSE,"2007-08-01","2010-08-01",1096,"Intovalue"
"NCT00586794","[No reason posted]",80,24,FALSE,"2007-12-01","2012-03-01",1552,"Intovalue"
"NCT00623415","[No reason posted]",80,30,FALSE,"2007-12-01","2012-11-01",1797,"Intovalue"
"NCT00628797","lack of recruitement",60,9,FALSE,"2008-02-01","2010-07-01",881,"Intovalue"
"NCT00647192","Inclusion rate too low. Recruitment of further study centers too costly.",220,38,FALSE,"2008-03-01","2012-02-01",1432,"Intovalue"
"NCT00663455","Recruitment goals were not achieved. Extension of the trial concept had to be abjected due to methodological reasons.",50,50,FALSE,"2008-12-01","2012-12-01",1461,"Intovalue"
"NCT00682747","poor recruitment",100,13,FALSE,"2008-05-01","2011-03-01",1034,"Intovalue"
"NCT00691912","Study was stopped due because recrutation.was much slower as anticipated.",6,26,FALSE,"2006-12-01","2013-12-01",2557,"Intovalue"
"NCT00704002","[No reason posted]",80,9,FALSE,"2006-12-01","2010-02-01",1158,"Intovalue"
"NCT00776191","al study sites stoped on 15&#x2F;05&#x2F;2012 because of insufficient recrutement.",25,5,FALSE,"2008-09-01","2012-05-01",1338,"Intovalue"
"NCT00806468","lack of recruitment",20,1,FALSE,"2009-02-01","2010-12-01",668,"Intovalue"
"NCT00823225","Insufficient recruitment of study patients",130,5,FALSE,"2008-06-01","2011-05-01",1064,"Intovalue"
"NCT00852059","Diffculties to recruit anticipated study size, now analysis",106,32,FALSE,"2009-03-01","2013-12-01",1736,"Intovalue"
"NCT00866684","Insufficient patient recruitment",280,44,FALSE,"2007-01-01","2011-01-01",1461,"Intovalue"
"NCT00881257","Data was inconclusive",50,78,FALSE,"2007-08-01","2009-11-01",823,"Intovalue"
"NCT00887276","[No reason posted]",290,290,FALSE,"2008-11-01","2011-01-01",791,"Intovalue"
"NCT00930241","logistic reasons (insufficient funding, technical problems with MEMS)",48,25,FALSE,"2009-07-01","2012-07-01",1096,"Intovalue"
"NCT00932724","The sponsor declared the early termination of the study due to poor recruitment of patients.",250,77,FALSE,"2009-07-01","2012-08-01",1127,"Intovalue"
"NCT00939939","Recruitment failure",40,3,FALSE,"2010-03-01","2011-05-01",426,"Intovalue"
"NCT00967343","[No reason posted]",70,40,TRUE,"2009-08-01","2012-02-01",914,"Intovalue"
"NCT01058369","Insufficient patient recruitment (only 2 patients)",45,2,TRUE,"2010-04-01","2013-01-01",1006,"Intovalue"
"NCT01058759","The external funding (pharmaceutical company) was stopped and could not be substituded by internal funding.",216,14,FALSE,"2009-11-01","2011-02-01",457,"Intovalue"
"NCT01069601","End of H1N1 Swine Flu Pandemic",120,13,FALSE,"2010-02-01","2011-04-01",424,"Intovalue"
"NCT01069965","Funding support withdrawn.",300,196,FALSE,"2010-10-01","2013-08-01",1035,"Intovalue"
"NCT01071135","Planned number of 30 subjects could not be recruited during recruitment phase.",NA,5,FALSE,"2009-09-01","2010-08-01",334,"Intovalue"
"NCT01088256","[No reason posted]",62,9,FALSE,"2011-02-01","2012-08-01",547,"Intovalue"
"NCT01088308","No enrollements for more than 6 months in Phase II",30,18,FALSE,"2010-03-01","2012-05-01",792,"Intovalue"
"NCT01098565","The goal of collecting proof-of-concept information was met through additional modeling studies, new published evidence and information collected from the study",25,6,FALSE,"2010-04-01","2011-11-01",579,"Intovalue"
"NCT01109966","[No reason posted]",228,34,FALSE,"2010-06-01","2012-10-01",853,"Intovalue"
"NCT01199133","Following the DSMB recommendation. Study population being insufficiently symptomatic to enable differentiation between treatment and placebo. No safety concerns",NA,471,FALSE,"2009-10-01","2011-01-01",457,"Intovalue"
"NCT01199783","Patient number to be enrolled not reachable in prospected time frame, decision to stop the study prematurely was made.",120,1,FALSE,"2011-07-01","2013-10-01",823,"Intovalue"
"NCT01231854","delayed start of the trial, both treatment options already have market authorizations, study medication expired",78,15,FALSE,"2010-11-01","2012-03-01",486,"Intovalue"
"NCT01298830","Need for improvement of study medication. Safety data collected sufficient. No further gain in knowledge expected.",20,11,FALSE,"2008-10-01","2011-06-01",973,"Intovalue"
"NCT01320280","unexpectedly slow recruitment",29,29,FALSE,"2011-05-01","2012-11-01",550,"Intovalue"
"NCT01341340","Discontinued due to poor enrollment. Insufficient number of patients enrolled to permit a statistically rigorous assessment of safety and efficacy.",90,2,FALSE,"2011-08-01","2012-11-01",458,"Intovalue"
"NCT01357460","difficult patient recruitment",25,18,FALSE,"2011-05-01","2014-09-24",1242,"Intovalue"
"NCT01363921","insufficient patient recruiting",12,10,FALSE,"2011-04-01","2013-09-01",884,"Intovalue"
"NCT01367691","[No reason posted]",20,1,FALSE,"2011-06-01","2013-12-01",914,"Intovalue"
"NCT01374789","The study was terminated due to insufficient recruitment.",124,2,FALSE,"2010-07-01","2014-04-01",1370,"Intovalue"
"NCT01409850","Very slow enrollment of participants",40,36,FALSE,"2010-07-01","2012-12-01",884,"Intovalue"
"NCT01410903","inadequately recruitment rate, funding is not secured",7,1,FALSE,"2011-04-01","2012-07-01",457,"Intovalue"
"NCT01434914","early termination due to poor recruitment",70,9,FALSE,"2011-10-01","2013-07-01",639,"Intovalue"
"NCT01447758","[No reason posted]",33,58,FALSE,"2011-09-01","2013-03-01",547,"Intovalue"
"NCT01458015","[No reason posted]",52,5,FALSE,"2011-10-01","2013-11-01",762,"Intovalue"
"NCT01531764","The recruitment was discontinued because of failure to meet expected enrolment goals",40,2,FALSE,"2012-07-01","2013-09-01",427,"Intovalue"
"NCT01551407","slow inclusion rate",34,38,FALSE,"2011-12-01","2012-06-01",183,"Intovalue"
"NCT01571895","Lack of efficacy observed at 1&#x2F;3 of the enrollment at investigated dosage. No results available.",12,4,FALSE,"2011-07-01","2012-06-01",336,"Intovalue"
"NCT01638585","recruition number was not reached",211,34,FALSE,"2011-06-01","2012-11-01",519,"Intovalue"
"NCT01701843","prematurely terminated because of low recruitment",30,7,FALSE,"2012-10-01","2013-02-01",123,"Intovalue"
"NCT01740544","[No reason posted]",40,16,FALSE,"2012-10-01","2012-12-01",61,"Intovalue"
"NCT02188212","[No reason posted]",NA,53,FALSE,"2010-03-01","2013-11-01",1341,"Intovalue"
"NCT00839059","Results of an interim analysis and a hardly ongoing enrolment in the last 10 months in all six participating centres",40,14,FALSE,"2009-01-01","2011-05-01",850,"Intovalue"
"NCT01476553","Prematurely halted after interim data analysis",64,30,FALSE,"2011-02-01","2013-12-01",1034,"Intovalue"
"NCT01589211","Necessary number of participants not achieved and high drop out rate",800,347,FALSE,"2011-12-16","2013-04-11",482,"Intovalue"
"NCT01352702","Slow recruitment; Study was terminated for futility reasons",70,46,FALSE,"2011-05-01","2014-05-01",1096,"Intovalue"
"NCT02207582","no efficacy",60,44,FALSE,"2014-07-01","2017-01-01",915,"Intovalue"
"NCT02372318","Anticipated nr of 25 probands was not reached in terms of full data sets (missing data, low fMRI data quality), but time frame for recruitment ended.",25,23,FALSE,"2015-04-01","2016-05-01",396,"Intovalue"
"NCT02129400","The analysis of the blood samples was much expensive than calculated. The recruitment had to be stopped after 36 study participants.",96,36,FALSE,"2014-05-01","2015-01-01",245,"Intovalue"
"NCT02135926","Results from other RCT made randomization unethical.",600,4,FALSE,"2014-03-01","2018-02-01",1433,"Intovalue"
"NCT01817738","Follow up period after primary analysis was prematurely stopped because more mature data will not impact the study outcome",200,197,FALSE,"2012-08-01","2016-08-01",1461,"Intovalue"
"NCT02034279","Low recruitment rate and expiration of the study drug",512,136,FALSE,"2014-05-01","2016-12-31",975,"Intovalue"
"NCT02340299","Slow recruitment",68,6,TRUE,"2015-01-01","2017-12-31",1095,"Intovalue"
"NCT01647880","delayed recruitment",88,15,FALSE,"2013-07-01","2016-04-01",1005,"Intovalue"
"NCT01440062","[No reason posted]",80,55,FALSE,"2011-12-01","2018-12-01",2557,"Intovalue"
"NCT01402739","Study terminated prematurely due to futility",116,100,FALSE,"2011-08-01","2015-06-01",1400,"Intovalue"
"NCT01111448","Unfavourable Risk-Benefit-Ratio",40,20,FALSE,"2010-04-01","2013-06-01",1157,"Intovalue"
"NCT02078986","[No reason posted]",50,50,FALSE,"2014-02-01","2015-02-01",365,"Intovalue"
"NCT01569412","[No reason posted]",24,14,FALSE,"2012-03-01","2016-05-01",1522,"Intovalue"
"NCT01067703","[No reason posted]",2070,1400,FALSE,"2010-12-01","2014-05-01",1247,"Intovalue"
"NCT01853384","based on outcome of trial NCT01656889.",440,252,TRUE,"2013-11-01","2015-12-01",760,"Intovalue"
"NCT01148264","poor enrolment",86,23,FALSE,"2010-07-01","2013-10-01",1188,"Intovalue"
"NCT01203228","[No reason posted]",160,129,FALSE,"2004-05-01","2015-01-01",3897,"Intovalue"
"NCT02384850","[No reason posted]",27,10,TRUE,"2015-03-01","2017-03-09",739,"Intovalue"
"NCT01900327","Recruitment failure",410,32,FALSE,"2014-02-01","2016-11-22",1025,"Intovalue"
"NCT01405417","not enough data collected",58,70,FALSE,"2011-04-01","2012-07-01",457,"Intovalue"
"NCT01931592","One of the study drugs was no longer available on a worldwide level.",47,29,FALSE,"2014-01-01","2016-10-01",1004,"Intovalue"
"NCT01852526","device failure",40,5,FALSE,"2013-03-01","2017-02-01",1433,"Intovalue"
"NCT02699034","Recommendation by BfArM after interim analysis",35,5,FALSE,"2016-03-01","2017-03-01",365,"Intovalue"
"NCT02380937","The study was terminated prematurely on 05May 2015 because of the unavailability of study devices.",30,8,FALSE,"2015-01-01","2015-08-01",212,"Intovalue"
"NCT00923793","Recruitment was stopped, due to slow recruitment rate",150,53,FALSE,"2009-06-01","2014-04-01",1765,"Intovalue"
"NCT01534455","very slow patient recruitment and concerns about the actuality of the study design",80,43,FALSE,"2012-02-01","2015-03-01",1124,"Intovalue"
"NCT02424552","recruitment problems",160,54,FALSE,"2015-06-26","2017-02-09",594,"Intovalue"
"NCT01679405","No sufficient clinical or molecular signals for efficacy were observed.",19,9,TRUE,"2012-08-01","2016-04-01",1339,"Intovalue"
"NCT01841632","[No reason posted]",12,3,TRUE,"2013-04-01","2016-12-01",1340,"Intovalue"
"NCT01540344","Slow recruitment.",60,26,FALSE,"2010-10-01","2015-09-01",1796,"Intovalue"
"NCT00950274","Recruitment stopped due to slow recruitment",142,81,FALSE,"2009-07-01","2016-03-01",2435,"Intovalue"
"NCT02052193","Second cohort not opened because Simon-Two_Step model failed",42,8,FALSE,"2014-01-01","2017-01-01",1096,"Intovalue"
"NCT01055522","[No reason posted]",129,102,FALSE,"2008-06-01","2013-02-01",1706,"Intovalue"
"NCT02820519","Intolerable high amount of adverse events",12,4,FALSE,"2016-06-01","2017-07-21",415,"Intovalue"
"NCT01532453","For futility reasons and potential &quot;loss of chance&quot; for MD 3511356 group",300,244,TRUE,"2010-11-01","2014-01-01",1157,"Intovalue"
"NCT03854942","Recruitment rate could not be met in the study period, review group was dissolved before regular end of study. Recruitment was therefore terminated.",120,43,FALSE,"2011-08-30","2017-12-13",2297,"Intovalue"
"NCT02585752","Low recruitment",NA,20,FALSE,"2015-10-01","2017-09-30",730,"Intovalue"
"NCT02539680","insufficiant recruitment",30,18,FALSE,"2015-09-01","2017-10-01",761,"Intovalue"
"NCT02077309","bad recruitment of suitable participants, just 4 patients in one year",60,4,FALSE,"2014-08-01","2015-09-01",396,"Intovalue"
"NCT01941550","Investigator left the site. Site closed.",35,11,FALSE,"2013-07-01","2016-01-01",914,"Intovalue"
"NCT01888796","bad recruitment of suitable participants, just 8 patients in one year",60,8,FALSE,"2013-09-01","2014-12-01",456,"Intovalue"
"NCT01341106","insufficient patient numbers have been recruited",100,7,FALSE,"2011-04-01","2015-01-01",1371,"Intovalue"
"NCT01266187","Recruitment difficulities",430,16,FALSE,"2011-07-01","2015-09-01",1523,"Intovalue"
"NCT01262729","Feasibility and Recruitment problems",100,5,FALSE,"2011-09-01","2014-11-01",1157,"Intovalue"
"NCT01242956","Problem to recruit sufficient patient number",400,100,FALSE,"2011-09-01","2014-11-01",1157,"Intovalue"
"NCT02475252","Recruitment too slow; study completion not possible within frame",150,15,FALSE,"2015-04-01","2016-01-01",275,"Intovalue"
"NCT01402414","Difficulties with the Recruitement",50,10,FALSE,"2011-04-01","2014-02-01",1037,"Intovalue"
"NCT01563614","No patients can be recruited for this trial anymore due to other therapeutical approaches that became available.",9,1,FALSE,"2012-03-01","2015-11-01",1340,"Intovalue"
"NCT02726048","Fisher &amp; Paykel Healthcare placed an administrative hold on the Simplus and Eson Non-Invasive Ventilation Evaluation study being conducted at Charite, Berlin",40,4,FALSE,"2016-04-01","2017-07-01",456,"Intovalue"
"NCT02019498","Recruitment problems",220,50,FALSE,"2014-04-01","2016-02-01",671,"Intovalue"
"NCT01523938","[No reason posted]",120,72,FALSE,"2012-03-01","2014-04-01",761,"Intovalue"
"NCT01370044","results of interim analysis (not safety relevant)",288,96,FALSE,"2012-08-01","2015-06-01",1034,"Intovalue"
"NCT01259830","[No reason posted]",90,81,FALSE,"2011-03-01","2014-04-01",1127,"Intovalue"
"NCT02157363","poor recruitment due to change of surgical technique",73,47,FALSE,"2014-06-01","2017-06-01",1096,"Intovalue"
"NCT01146821","Low enrollment&#x2F; expiration of the grant",21,7,FALSE,"2013-10-01","2017-04-01",1278,"Intovalue"
"NCT02595840","Futility",NA,4,FALSE,"2015-11-25","2017-11-20",726,"Intovalue"
"NCT02541357","Recruitment insufficient",108,4,FALSE,"2015-09-01","2017-03-01",547,"Intovalue"
"NCT02488694","unsufficient recruitment",210,4,FALSE,"2015-11-01","2017-12-01",761,"Intovalue"
"NCT02185703","Too slow recruitment rate",100,51,FALSE,"2014-07-01","2015-07-01",365,"Intovalue"
"NCT02150473","[No reason posted]",30,21,FALSE,"2014-10-01","2017-09-14",1079,"Intovalue"
"NCT01755871","lack of recruitment",250,8,FALSE,"2013-01-01","2016-01-01",1095,"Intovalue"
"NCT00977132","delayed recruitment",80,23,FALSE,"2009-10-01","2012-08-01",1035,"Intovalue"
"NCT01176214","slow recruitment of patients",100,7,FALSE,"2010-07-01","2014-04-01",1370,"Intovalue"
"NCT02081053","Difficulty Enrolling",40,30,FALSE,"2014-01-01","2016-11-01",1035,"Intovalue"
"NCT00945126","Poor accrural",45,68,FALSE,"2006-12-01","2017-08-01",3896,"Intovalue"
"NCT00711542","Slow recruitment",100,31,FALSE,"2008-09-01","2014-12-01",2282,"Intovalue"
"NCT01690572","recruitment was not sufficient.",30,14,FALSE,"2012-10-01","2016-12-01",1522,"Intovalue"
"NCT01517776","due to an altered benefit&#x2F;risk assessment.",33,28,FALSE,"2012-01-01","2014-03-01",790,"Intovalue"
"NCT01060423","Terminated due to poor subject enrolment",80,8,FALSE,"2010-02-01","2011-12-01",668,"Intovalue"
"NCT01045512","unsufficient recruitment",400,96,FALSE,"2009-10-01","2014-09-01",1796,"Intovalue"
"NCT02818959","Due to inability to recruit sufficient sample size in reasonable time frame.",NA,7,FALSE,"2013-12-01","2014-03-01",90,"Intovalue"
"NCT02606799","No further recruitment possible due to changed conditions",24,5,FALSE,"2016-05-01","2017-04-01",335,"Intovalue"
"NCT02417103","Recruiting failure",30,2,FALSE,"2011-12-01","2016-09-01",1736,"Intovalue"
"NCT02071511","The Sponsor appreciate the devastating impact that the results of the SYMPLICITY HTN 3 trial had on research progress for renal denervation. Based on the lack of recent progress, it is no longer practical to maintain the agreement.",50,50,FALSE,"2014-01-01","2016-01-01",730,"Intovalue"
"NCT01887041","Recruiting problems",128,24,FALSE,"2010-01-01","2015-12-01",2160,"Intovalue"
"NCT01759238","unexpectedly slow recruitment",72,1,FALSE,"2013-05-01","2014-10-01",518,"Intovalue"
"NCT01021202","unexpectedly slow recruitment",40,23,FALSE,"2009-10-01","2014-04-01",1643,"Intovalue"
"NCT00858793","A leukaemia case was reported in patient treated with a similar vector. For safety risk we stopped recruitment",10,5,FALSE,"2008-11-28","2016-08-31",2833,"Intovalue"
"NCT02728453","Insufficient recruitment.",60,7,FALSE,"2016-04-27","2017-09-25",516,"Intovalue"
"NCT02374567","[No reason posted]",2000,407,FALSE,"2015-01-01","2017-06-28",909,"Intovalue"
"NCT01336530","The study stopped prematurely due to and administrative reasons, not based on grounds of safety.",810,40,FALSE,"2011-04-01","2017-01-01",2102,"Intovalue"
"NCT01117662","The planned recruitment number of 180 Patient could not been achieved.",118,13,FALSE,"2012-05-01","2016-05-01",1461,"Intovalue"
"NCT02772146","After 2 patients it was concluded that a large change in exclusion criteria and study design was needed to obtain the ojective for the study",16,2,FALSE,"2016-05-11","2017-01-23",257,"Intovalue"
"NCT02130128","Sufficient clinical evidence was gathered",10,6,FALSE,"2014-04-01","2014-12-01",244,"Intovalue"
"NCT01666600","Interim Analysis for Feasibility",90,63,FALSE,"2012-08-01","2017-03-01",1673,"Intovalue"
"NCT01617980","Slow accrual",15,4,FALSE,"2012-04-01","2014-03-01",699,"Intovalue"
"NCT01362582","[No reason posted]",120,32,FALSE,"2010-03-01","2014-08-01",1614,"Intovalue"
"NCT00753441","Low patient accrual",100,24,FALSE,"2009-02-01","2017-08-16",3118,"Intovalue"
"NCT01522612","poor accrual",150,5,FALSE,"2013-04-01","2015-03-01",699,"Intovalue"
"NCT02641782","Antibody supply was discontinued by United Therapeutics Corporation.",36,3,FALSE,"2015-11-01","2016-12-23",418,"Intovalue"
"NCT02891863","Futility",NA,9,TRUE,"2015-09-01","2016-03-01",182,"Intovalue"
"NCT02523859","Poor recruitment",530,25,FALSE,"2015-07-01","2016-06-01",336,"Intovalue"
"NCT00595647","insufficient enrollment",240,162,FALSE,"2008-02-01","2014-03-01",2220,"Intovalue"
"NCT02039167","The recruitment rate was very poor. The study was stopped by amendment on 2015-08-28.",300,14,FALSE,"2014-01-01","2017-03-21",1175,"Intovalue"
"NCT02594332","recruitment problems",90,29,FALSE,"2015-11-17","2017-05-22",552,"Intovalue"
"NCT01340690","The sample size of the planned interims analysis was achieved",438,284,FALSE,"2011-03-08","2016-03-31",1850,"Intovalue"
"NCT00659867","Recruitment problems",200,182,FALSE,"2008-12-01","2014-03-01",1916,"Intovalue"
"NCT02312479","[No reason posted]",15,6,FALSE,"2014-12-01","2015-11-01",335,"Intovalue"
"NCT00834314","extended obligations of amended medical device law in Germany 2010 did not allow to continue and complete the trial due to budget limitation",20,3,FALSE,"2010-02-01","2014-05-01",1550,"Intovalue"
"NCT02675816","Study halted due to low recruitment. Reimbursement changes require a larger study with additional centers and therefore, a new study planned as replacement.",40,16,FALSE,"2015-08-01","2016-07-01",335,"Intovalue"
"NCT02139098","Recruiting problems because of the time expenditure required for participating and the strict criteria of inclusion and exclusion",150,23,FALSE,"2014-05-01","2017-11-01",1280,"Intovalue"
"NCT02207309","poor recruitment",150,1,FALSE,"2015-06-22","2016-07-29",403,"Intovalue"
"NCT01690325","Therapy of HER2+ patients according to protocol was no longer appropriate. Patient enrolment behind planned schedule and challenges of site performance",94,21,FALSE,"2012-09-01","2016-11-01",1522,"Intovalue"
"NCT01439958","Core study 12011.201 was terminated.",75,14,FALSE,"2012-02-01","2013-07-01",516,"Intovalue"
"NCT01419002","lack of recruitment",120,5,FALSE,"2011-10-01","2014-10-01",1096,"Intovalue"
"NCT01407679","[No reason posted]",30,7,FALSE,"2011-08-01","2014-10-01",1157,"Intovalue"
"NCT01303250","The final decision of the review of HES-containing solution shall be awaited.",170,31,FALSE,"2011-04-01","2015-04-01",1461,"Intovalue"
"NCT00413127","Less patients than expected for inclusion, therefore patient recruitment is to low",150,78,FALSE,"2007-09-01","2014-03-01",2373,"Intovalue"
"NCT02058810","Lack of patients, PI left",100,46,FALSE,"2010-09-01","2014-05-01",1338,"Intovalue"
"NCT02739685","Slow enrollment, access to devices",144,17,FALSE,"2016-09-01","2018-05-01",607,"Intovalue"
"NCT02632292","Slow enrollment",224,33,FALSE,"2016-01-01","2018-04-01",821,"Intovalue"
"NCT01312623","Terminated, because it is not possible to recruit enough participants",180,31,FALSE,"2010-03-01","2016-03-01",2192,"Intovalue"
"NCT02140138","Recruitment was terminated after enrolment of 35 instead of 36 evaluable patients for administrative reasons.",36,35,FALSE,"2014-06-01","2016-04-01",670,"Intovalue"
"NCT01683864","Recruitment problems",60,3,TRUE,"2012-09-01","2015-05-01",972,"Intovalue"
"NCT01582048","slow enrollment",60,9,FALSE,"2012-04-01","2016-08-17",1599,"Intovalue"
"NCT01289938","To unsuccessful recruitment of rare UM-genotype. All other planned genotype groups are completed (EM, IM and PM).",42,49,FALSE,"2009-07-01","2015-06-01",2161,"Intovalue"
"NCT00961142","slow recruitment",60,23,FALSE,"2009-06-01","2015-12-30",2403,"Intovalue"
"NCT02198482","development program of study drug volasertib was stopped by Boehringer Ingelheim due to manufacturing problems",352,6,FALSE,"2016-02-01","2016-11-01",274,"Intovalue"
"NCT01837082","Insufficient recruitment",100,18,FALSE,"2013-04-01","2015-12-01",974,"Intovalue"
"NCT01397149","Insufficient recruitment",82,4,FALSE,"2011-10-01","2013-11-01",762,"Intovalue"
"NCT01611207","The patient recruitment was behind target, no successful completion of the planned patient numbers within trial period could be expected",250,12,FALSE,"2012-06-01","2013-12-01",548,"Intovalue"
"NCT01165450","Drug manufacturer could not supply study drug.",72,2,TRUE,"2011/11/01 00:00:00","2014-02-01",823,"Contrast"
"NCT00506909","Break in funding",40,21,TRUE,"2008/03/01 00:00:00","2014-03-01",2191,"Contrast"
"NCT00470548","Practice patterns with pemetrexed have evolved.",73,49,TRUE,"2007/04/01 00:00:00","2014-10-01",2740,"Contrast"
"NCT01614067","Slow enrollment resulted in withdraw of funding",114,30,TRUE,"2012/05/01 00:00:00","2014-07-01",791,"Contrast"
"NCT01061671","Futility",1126,885,TRUE,"2010/03/01 00:00:00","2014-01-01",1402,"Contrast"
"NCT02566278","Data collection has been halted. We are not recruiting any more subjects.",20,20,FALSE,"2015/10/20 00:00:00","2016-07-25",279,"Contrast"
"NCT01373918","The study was terminated due to slow enrollment.",120,41,TRUE,"2010/12/01 00:00:00","2014-07-01",1308,"Contrast"
"NCT02120027","Because of negative results of the sister study NAK-06 and the low overall response rate at week 24.",500,558,TRUE,"2014/02/01 00:00:00","2015-10-01",579,"Contrast"
"NCT01963403","Futility of recruitment",130,26,TRUE,"2013/12/01 00:00:00","2015-08-01",608,"Contrast"
"NCT01123161","The ICTuS 2 portion of the trial has been halted and data will be analyzed.",400,120,TRUE,"2010/06/01 00:00:00","2015-04-01",1765,"Contrast"
"NCT01261299","Contract ended",80,21,FALSE,"2010/12/01 00:00:00","2017-06-01",2374,"Contrast"
"NCT02605304","The study experienced enrollment difficulties.",40,7,TRUE,"2016/02/17 00:00:00","2017-01-20",338,"Contrast"
"NCT02215161","Risk to benefit ratio is not acceptable",54,14,TRUE,"2014/09/02 00:00:00","2017-02-15",897,"Contrast"
"NCT02428309","Due to participant recruitment feasibility",18,1,TRUE,"2015/08/27 00:00:00","2016-09-02",372,"Contrast"
"NCT01116661","The primary objective for high grade gliomas has been met and the FDA has now approved the drug (Gleolan) for use in the United States.",50,199,TRUE,"2010/08/01 00:00:00","2017-12-28",2706,"Contrast"
"NCT02147301","Risk to benefit ratio is not acceptable",51,17,TRUE,"2014/12/17 00:00:00","2017-01-27",772,"Contrast"
"NCT02444793","The study was terminated due to marginal efficacy and change in sponsor prioritization. The combination had a manageable safety profile.",70,24,TRUE,"2015/05/01 00:00:00","2017-09-26",854,"Contrast"
"NCT02465983","Lack of efficacy and funding to continue investigation",12,4,FALSE,"2015/05/01 00:00:00","2017-09-01",854,"Contrast"
"NCT02205307","Slow recruitment",800,347,TRUE,"2015/01/01 00:00:00","2017-05-01",851,"Contrast"
"NCT02254902","Changes in funding status",100,27,FALSE,"2014/09/01 00:00:00","2015-12-01",456,"Contrast"
"NCT01601626","The study was stopped early due to feasibility concerns.",426,71,TRUE,"2013/07/13 00:00:00","2017-01-19",1286,"Contrast"
"NCT01098422","Halted due to slow enrollment",34,10,TRUE,"2010/01/01 00:00:00","2015-01-01",1826,"Contrast"
"NCT02093962","At the interim analysis, the futility boundary was not met and the study was stopped due to insufficient efficacy.",440,265,TRUE,"2014/06/01 00:00:00","2016-04-01",670,"Contrast"
"NCT02508441","Part 1 of the study was completed and the maximum tolerated dose determined. Part 2 of the study was terminated and will be conducted under a new protocol.",76,22,FALSE,"2015/12/08 00:00:00","2017-11-13",706,"Contrast"
"NCT01562132","Stopped in accordance with pre-specified stopping rules for poor recruitment.",100,6,TRUE,"2013/09/01 00:00:00","2014-07-01",303,"Contrast"
"NCT01841307","Difficulty recruiting; Funding ended; interim analysis provided sufficient data for interpretation.",15,16,FALSE,"2015/07/01 00:00:00","2017-03-01",609,"Contrast"
"NCT01313923","Lack of funding",15,3,TRUE,"2011/02/01 00:00:00","2014-10-01",1338,"Contrast"
"NCT01510756","slow enrollment",10,4,TRUE,"2011/12/01 00:00:00","2014-05-01",882,"Contrast"
"NCT01838499","At the planned IA for decision making, no evidence was demonstrated of MEDI8968 activity in reducing (HS) severity or pain over that seen with placebo.",100,224,TRUE,"2013/05/01 00:00:00","2014-10-01",518,"Contrast"
"NCT01391949","[No reason posted]",70,7,FALSE,"2011/07/01 00:00:00","2015-06-01",1431,"Contrast"
"NCT02046928","Slow enrollment",20,5,FALSE,"2014/02/01 00:00:00","2015-11-01",638,"Contrast"
"NCT02327637","Low recruitment",130,5,FALSE,"2014/12/01 00:00:00","2016-12-12",742,"Contrast"
"NCT00771862","Could not secure funding to complete the study.",30,16,FALSE,"2008/10/01 00:00:00","2017-05-30",3163,"Contrast"
"NCT02644122","Slow enrollment",29,1,TRUE,"2016/11/01 00:00:00","2017-06-01",212,"Contrast"
"NCT02177773","FDA approved agent for this indication during enrollment",120,300,TRUE,"2014/06/23 00:00:00","2017-08-07",1141,"Contrast"
"NCT02078895","The study was terminated due to low enrollment",80,15,FALSE,"2014/02/01 00:00:00","2017-02-01",1096,"Contrast"
"NCT02591381","Study was started but closed prior to completion because we could not meet enrollment numbers",400,3,FALSE,"2015/10/01 00:00:00","2017-10-01",731,"Contrast"
"NCT02719730","Change in study design to be a pilot with no randomization to intervention&#x2F;control",60,5,FALSE,"2016/06/22 00:00:00","2016-08-02",41,"Contrast"
"NCT02317276","Unable to meet the study&#x27;s recruitment goals",15,11,TRUE,"2014/12/01 00:00:00","2017-04-06",857,"Contrast"
"NCT02634606","Unable to obtain supplement for this study. Unable to recruit.",NA,13,TRUE,"2011/03/22 00:00:00","2017-10-01",670,"Contrast"
"NCT02745353","Couldn&#x27;t enough accrue patients",60,7,TRUE,"2016/05/01 00:00:00","2017-06-22",417,"Contrast"
"NCT02368691","Lack of Efficacy",55,32,TRUE,"2015/06/01 00:00:00","2017-09-22",844,"Contrast"
"NCT01390584","slow accrual",200,6,TRUE,"2012/04/02 00:00:00","2014-01-01",640,"Contrast"
"NCT01683747","Lower than anticipated enrollment",200,4,FALSE,"2012/06/01 00:00:00","2014-11-01",883,"Contrast"
"NCT01829347","Due to results from the VTI-208 study, the ELAD plan is being re-evaluated.",100,18,TRUE,"2014/04/01 00:00:00","2015-10-01",548,"Contrast"
"NCT02354092","[No reason posted]",108,14,TRUE,"2015/04/02 00:00:00","2015-08-25",145,"Contrast"
"NCT02605824","The study was closed after we determined that this albuterol&#x2F;NAC regimen may be associated with excessive bronchoconstriction.",20,1,TRUE,"2016/03/01 00:00:00","2017-12-01",640,"Contrast"
"NCT01545648","Low Accrual",45,4,TRUE,"2012/11/01 00:00:00","2015-06-09",950,"Contrast"
"NCT00632827","Manufacturing shortage of both Diftitox and Doxil",45,21,TRUE,"2008/07/01 00:00:00","2014-06-23",2183,"Contrast"
"NCT01641601","Inadequate enrollment. Key study personnel transitioned to a different role.",80,8,TRUE,"2012/07/01 00:00:00","2015-07-01",1095,"Contrast"
"NCT02567448","Failed to accrue",100,24,FALSE,"2015/07/01 00:00:00","2016-08-11",407,"Contrast"
"NCT01821443","Loss of funding",45,10,FALSE,"2012/12/01 00:00:00","2015-10-22",1055,"Contrast"
"NCT01709474","Due to slow enrollment",78,7,TRUE,"2013/06/01 00:00:00","2014-07-01",395,"Contrast"
"NCT02307552","The probe could not be anchored in place and would rotate about its axis, thus comparison was difficult.",10,1,TRUE,"2013/06/01 00:00:00","2014-04-01",304,"Contrast"
"NCT01721603","Low accrual",39,2,TRUE,"2013/04/01 00:00:00","2016-01-01",1005,"Contrast"
"NCT01780636","POOR RECRUITMENT",30,7,TRUE,"2013/01/01 00:00:00","2014-01-01",365,"Contrast"
"NCT02294981","Protocol was changed to make it easier for treating doctors. No safety concerns",30,4,TRUE,"2016/01/01 00:00:00","2017-09-01",609,"Contrast"
"NCT02524106","Industry won&#x27;t be moving forward with production of bococizumab",200,11,TRUE,"2016/08/01 00:00:00","2019-04-01",973,"Contrast"
"NCT01211756","Break in funding",20,1,TRUE,"2010/10/01 00:00:00","2015-02-01",1584,"Contrast"
"NCT02672033","slow enrollment",10,2,TRUE,"2015/09/01 00:00:00","2018-07-17",1050,"Contrast"
"NCT01046773","Low enrollment",20,3,FALSE,"2010/01/01 00:00:00","2017-05-01",2677,"Contrast"
"NCT01773746","Poor Recruitment",1260,80,FALSE,"2013/08/01 00:00:00","2017-03-01",1308,"Contrast"
"NCT01617291","A similar study was recently published with definitive results.",400,46,FALSE,"2013/03/01 00:00:00","2014-02-01",337,"Contrast"
"NCT01737593","Interim analysis revealed a negative effect.",246,108,TRUE,"2012/11/01 00:00:00","2014-04-01",516,"Contrast"
"NCT01943188","[No reason posted]",14,2,FALSE,"2014/05/01 00:00:00","2016-03-01",670,"Contrast"
"NCT02381392","Insufficient enrollment, investigator left institution",260,23,TRUE,"2014/08/01 00:00:00","2016-11-19",841,"Contrast"
"NCT01290523","Off study clinical use of Y90 glass microspheres (TheraSphere)",30,14,TRUE,"2010/05/01 00:00:00","2014-05-01",1461,"Contrast"
"NCT01778855","[No reason posted]",120,6,TRUE,"2013/02/01 00:00:00","2015-08-01",911,"Contrast"
"NCT01502761","No safety issues. Low enrollment secondary to negative stroke studies 2013",20,4,TRUE,"2012/03/01 00:00:00","2016-05-01",1522,"Contrast"
"NCT00610467","Slow accrual",120,2,TRUE,"2006/10/01 00:00:00","2016-10-01",3653,"Contrast"
"NCT02170298","Lack of enrollment",40,6,TRUE,"2014/02/01 00:00:00","2015-06-01",485,"Contrast"
"NCT01402544","Per study sponsor decision.",40,20,TRUE,"2011/07/01 00:00:00","2015-03-01",1339,"Contrast"
"NCT00751101","Low Accrual",80,24,TRUE,"2007/08/20 00:00:00","2014-03-24",2408,"Contrast"
"NCT02728700","Accrual factor",9,1,FALSE,"2016/02/01 00:00:00","2018-07-01",881,"Contrast"
"NCT01615042","Lack of enrollment",18,6,FALSE,"2012/08/01 00:00:00","2017-05-01",1734,"Contrast"
"NCT01138553","Inadequate subject accrual",66,4,FALSE,"2010/06/01 00:00:00","2014-06-01",1461,"Contrast"
"NCT02280395","Company merger resulted in business decision to terminate the study.",150,9,FALSE,"2014/10/01 00:00:00","2015-06-01",243,"Contrast"
"NCT01826305","[No reason posted]",120,23,FALSE,"2014/07/01 00:00:00","2015-10-23",479,"Contrast"
"NCT02450201","Low accrual",10,5,FALSE,"2016/10/12 00:00:00","2017-01-17",97,"Contrast"
"NCT01695473","Lack of Accrual",24,11,TRUE,"2013/04/23 00:00:00","2015-02-05",653,"Contrast"
"NCT01442714","Lack of efficacy - Inability to meet the primary response endpoint",50,33,TRUE,"2011/08/01 00:00:00","2014-08-01",1096,"Contrast"
"NCT01055028","Poor accrual",20,18,TRUE,"2010/02/01 00:00:00","2016-03-01",2220,"Contrast"
"NCT02206776","poor tolerability and low enrollment rate",50,2,TRUE,"2014/09/01 00:00:00","2015-05-01",242,"Contrast"
"NCT01719861","Lack of efficacy",10,6,TRUE,"2012/10/01 00:00:00","2014-05-01",577,"Contrast"
"NCT01965002","Accrual factor",30,5,TRUE,"2014/05/01 00:00:00","2015-03-24",327,"Contrast"
"NCT02855086","logistics",10,3,TRUE,"2016/10/01 00:00:00","2016-11-08",38,"Contrast"
"NCT02736578","Logistics",10,8,TRUE,"2016/07/01 00:00:00","2017-04-24",297,"Contrast"
"NCT02757547","Business decision to discontinue development of this investigational device.",10,2,TRUE,"2015/09/01 00:00:00","2017-11-15",806,"Contrast"
"NCT01034514","business decision",30,35,FALSE,"2009/12/01 00:00:00","2014-06-24",1666,"Contrast"
"NCT01094587","Enrollment difficulty",54,39,FALSE,"2009/11/01 00:00:00","2015-06-24",2061,"Contrast"
"NCT01123005","Logistical",40,28,FALSE,"2010/12/01 00:00:00","2015-08-21",1724,"Contrast"
"NCT01987375","logistics",12,1,FALSE,"2015/11/01 00:00:00","2017-04-19",535,"Contrast"
"NCT01067144","Trial met futility stopping point",560,422,TRUE,"2010/05/01 00:00:00","2016-07-01",2253,"Contrast"
"NCT02586415","Interim analysis showed a high likelihood of benefit in the endovascular group",476,182,TRUE,"2016/04/01 00:00:00","2017-08-01",487,"Contrast"
"NCT02303041","Business Decision",40,10,TRUE,"2015/02/01 00:00:00","2017-04-01",790,"Contrast"
"NCT01020812","enrollment was too low",24,11,TRUE,"2009/09/01 00:00:00","2014-03-01",1642,"Contrast"
"NCT01506726","Study drug expiration and supply shortage",60,11,TRUE,"2012/03/01 00:00:00","2014-10-01",944,"Contrast"
"NCT01868503","Protocol modification",22,7,TRUE,"2013/07/01 00:00:00","2014-12-01",518,"Contrast"
"NCT01406795","Poor enrollment and advances in venoplasty only techniques of the femoral vein",15,1,TRUE,"2010/12/01 00:00:00","2014-12-01",1461,"Contrast"
"NCT01313884","Study did not reach primary objective; study did not accrue enough patients.",20,3,TRUE,"2011/05/01 00:00:00","2013-11-01",915,"Contrast"
"NCT01893879","insufficient enrollment",120,14,TRUE,"2014/04/01 00:00:00","2015-04-01",365,"Contrast"
"NCT01928030","Low accrual",23,3,TRUE,"2013/12/01 00:00:00","2015-11-01",700,"Contrast"
"NCT01364259","Patterns of practice changed and this technique is no longer used.",208,17,TRUE,"2008/09/01 00:00:00","2014-01-01",1948,"Contrast"
"NCT01769222","Planned Future Study",69,3,TRUE,"2013/02/01 00:00:00","2014-11-01",638,"Contrast"
"NCT03023709","Due to the ACIP guidelines halting the use of LAIV",NA,3,TRUE,"2015/09/01 00:00:00","2015-12-01",91,"Contrast"
"NCT01823679","Low accrual",19,2,TRUE,"2013/03/01 00:00:00","2014-05-01",426,"Contrast"
"NCT02030405","Regulatory",16,4,TRUE,"2014/03/01 00:00:00","2015-11-01",610,"Contrast"
"NCT02175745","Re-evaluate indication with the referring physicians",50,2,TRUE,"2014/12/01 00:00:00","2015-08-01",243,"Contrast"
"NCT03028987","LAIV was no longer recommended by ACIP",12,10,TRUE,"2014/11/19 00:00:00","2015-11-18",364,"Contrast"
"NCT00481832","Accrual Factor",25,50,TRUE,"2007/01/01 00:00:00","2014-10-27",2856,"Contrast"
"NCT02877732","The funding sponsor elected to terminate the study.",100,12,TRUE,"2016/07/01 00:00:00","2017-04-01",274,"Contrast"
"NCT02415608","Slow accrual",11,4,TRUE,"2015/03/01 00:00:00","2017-03-14",744,"Contrast"
"NCT01846624","Accrual factor",36,13,TRUE,"2013/06/01 00:00:00","2016-07-22",1147,"Contrast"
"NCT03206216","Business decision",50,1,TRUE,"2017/08/04 00:00:00","2017-10-30",87,"Contrast"
"NCT01472445","Slow accrual",60,41,TRUE,"2011/11/01 00:00:00","2014-10-01",1065,"Contrast"
"NCT00568633","Poor accrual",150,58,TRUE,"2007/08/01 00:00:00","2017-12-01",3775,"Contrast"
"NCT03061279","Problem negotiating other sites",500,1,TRUE,"2017/04/01 00:00:00","2017-10-26",208,"Contrast"
"NCT01745354","Accrual issues - Slow accrual",12,6,FALSE,"2012/08/01 00:00:00","2014-11-01",822,"Contrast"
"NCT01857752","accrual",16,3,FALSE,"2012/03/01 00:00:00","2015-06-01",1187,"Contrast"
"NCT01904643","Accrual factor",30,17,FALSE,"2014/02/01 00:00:00","2015-05-13",466,"Contrast"
"NCT02075190","Dr. Gyurak is no longer doing and ended her NARSAD early.",150,89,FALSE,"2014/02/01 00:00:00","2015-08-01",546,"Contrast"
"NCT02436460","Re-initiate a new trial per the discussion with FDA",12,4,FALSE,"2015/05/01 00:00:00","2016-03-01",305,"Contrast"
"NCT02042157","Equipment malfunction.",400,28,FALSE,"2015/01/01 00:00:00","2016-12-01",700,"Contrast"
"NCT02890875","Low recruitment",40,3,FALSE,"2016/08/01 00:00:00","2018-09-01",761,"Contrast"
"NCT01188486","Business decision",12,12,FALSE,"2010/08/01 00:00:00","2017-04-30",2464,"Contrast"
"NCT02429804","Accrual factor",15,4,FALSE,"2015/04/01 00:00:00","2017-05-15",775,"Contrast"
"NCT02435225","Change in goals of PI",50,14,FALSE,"2014/05/01 00:00:00","2014-06-01",31,"Contrast"
"NCT02708511","[No reason posted]",10,2,FALSE,"2016/08/01 00:00:00","2017-10-11",436,"Contrast"
"NCT02049801","logistics",19,1,FALSE,"2014/12/01 00:00:00","2015-02-04",65,"Contrast"
"NCT02635074","safety",18,2,FALSE,"2016/11/01 00:00:00","2017-07-18",259,"Contrast"
"NCT01192776","The trial closed for emerging safety profile and futility analysis and will not resume.",726,364,TRUE,"2010/09/01 00:00:00","2016-03-01",2008,"Contrast"
"NCT01954082","Study terminated due to safety concerns; participant follow up will continue until March 2018",1760,638,TRUE,"2014/04/17 00:00:00","2016-06-01",792,"Contrast"
"NCT01614652","Company is closed",478,331,FALSE,"2012/12/01 00:00:00","2017-06-01",1643,"Contrast"
"NCT02057991","Insufficient Accrual",300,94,FALSE,"2014/01/07 00:00:00","2017-01-01",1096,"Contrast"
"NCT03115385","Funds ended.",NA,22,FALSE,"2015/05/30 00:00:00","2016-04-11",317,"Contrast"
"NCT01302405","closing due to low enrollment, no safety issues",64,23,FALSE,"2011/02/01 00:00:00","2015-01-01",1430,"Contrast"
"NCT01153919","Approval of several new agents for the treatment of HCV infection would mitigate the future need for interferon HCV treatment",36,27,FALSE,"2010/06/30 00:00:00","2014-07-14",1475,"Contrast"
"NCT01801046","Insufficient Accrual",35,10,FALSE,"2013/03/06 00:00:00","2017-07-27",1604,"Contrast"
"NCT01238965","Adverse Events",50,7,FALSE,"2010/10/01 00:00:00","2015-06-01",1704,"Contrast"
"NCT00556907","Lack of Funding",116,22,FALSE,"2007/10/01 00:00:00","2013-12-01",2253,"Contrast"
"NCT01469338","lack of funding",50,9,FALSE,"2012/07/01 00:00:00","2014-10-01",822,"Contrast"
"NCT02967380","Insufficient Accrual",NA,14,FALSE,"2011/12/14 00:00:00","2014-05-01",882,"Contrast"
"NCT02270684","Recruitment and retention difficulties",50,4,TRUE,"2015/05/01 00:00:00","2016-01-01",245,"Contrast"
"NCT01866423","Not progressing toward scientific goals",50,4,TRUE,"2013/10/25 00:00:00","2015-10-01",730,"Contrast"
"NCT01518465","Insufficient Accrual",30,13,FALSE,"2012/01/09 00:00:00","2016-12-31",1818,"Contrast"
"NCT02370264","Study not progressing toward scientific goals",150,36,FALSE,"2012/10/01 00:00:00","2015-09-02",1066,"Contrast"
"NCT02127892","Closed due to slow accrual. Nine subjects enrolled over 7 years.",15,9,TRUE,"2007/01/02 00:00:00","2016-08-01",3499,"Contrast"
"NCT03104816","Could not get an approval from Department Reviewer for the study continuation.",128,28,TRUE,"2016/10/01 00:00:00","2017-10-01",365,"Contrast"
"NCT01649258","Lack of Efficacy",39,29,FALSE,"2012/09/04 00:00:00","2017-09-04",1826,"Contrast"
"NCT02067884","Slow accrual",50,34,FALSE,"2013/12/19 00:00:00","2016-09-25",1011,"Contrast"
